A detailed history of Nia Impact Advisors, LLC transactions in Rezolute, Inc. stock. As of the latest transaction made, Nia Impact Advisors, LLC holds 11,454 shares of RZLT stock, worth $113,509. This represents 0.04% of its overall portfolio holdings.

Number of Shares
11,454
Holding current value
$113,509
% of portfolio
0.04%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025

BUY
$4.42 - $9.34 $50,626 - $106,980
11,454 New
11,454 $106,000

Others Institutions Holding RZLT

About Rezolute, Inc.


  • Ticker RZLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,827,600
  • Market Cap $385M
  • Description
  • Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultr...
More about RZLT
Track This Portfolio

Track Nia Impact Advisors, LLC Portfolio

Follow Nia Impact Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nia Impact Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nia Impact Advisors, LLC with notifications on news.